Mepolizumab decreases exacerbations in patients with eosinophilic COPD
1. In this randomized controlled trial, mepolizumab decreased the annualized rate of moderate or severe exacerbations when added to triple...
Wellness
Single-dose baloxavir linked to reduced influenza transmission
1. In this randomized controlled trial, influenza-positive patients who received a single dose of baloxavir had a 29% lower adjusted...
Male partner treatment lowers the risk of bacterial vaginosis reoccurrence
1. In this randomized controlled trial, female patients with bacterial vaginosis (BV) had lower recurrence rates when their male partner...
Low-dose yellow fever vaccine non-inferior to standard dose
1. This randomized controlled trial conducted in Kenya and Uganda assessed whether fractional doses of the 17D-204 yellow fever vaccine...
Emerging highly pathogenic avian influenza A(H5N1) infections in humans
1. In this case series, of the reported 46 case-patients, 45 cases were due to exposures to infected poultry or...
Mpox cases in Africa continued to increase following WHO emergency declarations
1. The number of mpox cases in Africa increased leading up to the first mpox declaration of a Public Health...
Avian Influenza A(H5N1) caused mild illness in the exposed U.S. population
1. In this case series, agricultural workers who contracted A(H5N1) experienced mild illnesses of short duration, with no reported fatalities....
Levofloxacin shows limited efficacy in preventing multidrug-resistant tuberculosis
1. In this randomized controlled trial, daily levofloxacin treatment in patients with multidrug-resistant (MDR) or rifampicin-resistant Mycobacterium tuberculosis did not...
Levofloxacin does not prevent infection in children exposed to MDR tuberculosis
1. In this randomized controlled trial, among children and adolescents with household exposure to an adult with multidrug-resistant tuberculosis, it...
rVSV-ZEBOV-GP ring vaccination reduces the incidence of Ebola virus disease
1. In the outbreak of Ebola virus disease (EVD) in the Democratic Republic of Congo (DRC) between 2018 and 2020,...